The Glomerulus & Mechanisms

The contract between this chapter and the reader.

1. 1. Describe the structure of the glomerulus.
2. 2. Explain the three-layer filtration barrier.
3. 3. Explain how the barrier filters by size and charge.
4. 4. Identify the cells of the glomerulus and their roles.
5. 5. Classify the immune mechanisms of glomerular injury.
6. 6. Classify the non-immune mechanisms of glomerular injury.
7. 7. Link the cell injured to the pattern of disease.
8. 8. Describe the descriptive and immunofluorescence patterns.
9. 9. Link mechanism to the nephrotic and nephritic syndromes.

A sixty-second reading. Each bullet stands alone.

• The glomerulus is the kidney's filtering unit, a capillary tuft between afferent and efferent arterioles.
• Its filtration barrier has three layers: fenestrated endothelium, the basement membrane, and podocytes.
• The barrier filters by size and charge, retaining albumin and larger molecules.
• The podocyte slit diaphragm (nephrin, podocin) is the final barrier to protein.
• The mesangium supports the tuft and handles immune complexes — the site of IgA deposits.
• Immune injury includes immune-complex, anti-GBM, pauci-immune (ANCA), and complement-driven disease.
• Non-immune injury includes hemodynamic (hyperfiltration), metabolic, genetic, and direct podocyte injury.
• The cell injured determines the pattern: podocyte injury causes proteinuria; inflammatory injury causes hematuria.
• Podocyte injury produces a nephrotic picture; endothelial or mesangial inflammation a nephritic one.
• Severe injury produces crescents from the parietal epithelium.
• Immunofluorescence patterns — granular, linear, pauci-immune, mesangial, C3-dominant — point to the mechanism.
• Podocytes are terminally differentiated, so their loss drives glomerulosclerosis.
• Glomerular diseases progress toward interstitial fibrosis and tubular atrophy.

The medical core. An expert should agree the glomerulus and its mechanisms of injury are fully covered here.

Why it matters at the bedside

Every glomerular disease in this book is, at heart, a story about which part of one tiny filter broke and why. Learn the glomerulus — its three-layer barrier and its four cells — and the bewildering catalogue of glomerulonephritides resolves into a logic: the cell injured sets the syndrome, the mechanism sets the pattern, and the biopsy reads them both. This chapter is the map the rest of the volume is drawn on.

The structure of the glomerulus

• The glomerulus is the kidney's filtering unit — around a million per kidney — a tuft of specialised capillaries fed by an afferent arteriole and drained by an efferent one, encased in Bowman's capsule. Blood is filtered across the capillary wall into Bowman's space and on into the tubule. Its behaviour in health and disease follows from its architecture.

The three-layer filtration barrier

• The capillary wall is a three-layer barrier. The fenestrated endothelium, coated in a charged glycocalyx, is the first layer. The glomerular basement membrane (GBM) — built of type IV collagen (the α3α4α5 network, the target in Alport and anti-GBM disease) and laminin — is the middle layer. And the podocytes (visceral epithelial cells) wrap the capillary with interdigitating foot processes bridged by the slit diaphragm. Together these retain protein while letting water and small solutes through.

How the barrier filters

• Filtration is selective by size and charge: small, neutral, or positively-charged molecules pass freely, while large or negatively-charged ones (notably albumin) are held back — repelled by the barrier's fixed negative charge and excluded by its size limit. The podocyte slit diaphragm, with its proteins nephrin and podocin, is the decisive final barrier to protein; when it is damaged and the foot processes efface, protein floods into the urine.

The cells and their roles

• Four cell types matter. Endothelial cells line the capillary (their injury underlies thrombotic microangiopathy and contributes to nephritic disease). Podocytes are the protein barrier (their injury causes proteinuria — minimal change, FSGS, membranous). Mesangial cells support the tuft, are contractile, and handle immune complexes — the site where IgA deposits. And the parietal epithelial cells lining Bowman's capsule are the source of the crescents that mark severe injury.

Immune mechanisms of injury

• Immune injury comes in recognisable modes. Immune-complex disease — complexes formed in situ or deposited from the circulation — triggers complement and inflammation and shows granular immunofluorescence (lupus, IgA, post-infectious, membranous via in-situ anti-PLA2R). Anti-GBM disease is antibody directed at GBM collagen IV, giving linear staining and crescents. Pauci-immune (ANCA) disease is neutrophil-mediated with few deposits (the vasculitis chapter). And complement dysregulation drives C3 glomerulopathy and atypical HUS.

Non-immune mechanisms of injury

• Not all glomerular injury is immune. Hemodynamic injury — hyperfiltration from diabetes, reduced nephron mass, or obesity — stresses podocytes and produces secondary focal segmental glomerulosclerosis. Metabolic and deposition diseases (diabetic nephropathy, amyloid, light chains) infiltrate the tuft. Genetic defects strike the podocyte (FSGS genes) or collagen IV (Alport). And direct podocyte injury — a circulating permeability factor in primary FSGS, or toxins and viruses — attacks the barrier head-on.

The cell injured determines the pattern

• The unifying principle is that the cell injured sets the clinical pattern. Injure the podocyte and the barrier leaks protein — a nephrotic, bland-sediment picture. Inflame the endothelium and mesangium and the wall bleeds and proliferates — a nephritic picture with haematuria and red-cell casts. Damage the GBM with antibody, or overwhelm the glomerulus, and the parietal cells form crescents — rapidly progressive disease. Localising the injury is the first diagnostic move.

The descriptive and immunofluorescence patterns

• Pathology adds two vocabularies. The descriptive one captures extent: focal versus diffuse (fewer or more than half the glomeruli), segmental versus global (part or all of a tuft), and proliferative versus membranous versus sclerotic. The immunofluorescence one points to mechanism: granular (immune-complex), linear (anti-GBM), pauci-immune (ANCA), mesangial IgA (IgA nephropathy), and C3-dominant (C3 glomerulopathy). Together they name the lesion.

Linking mechanism to syndrome

• These threads converge on the two great syndromes, developed in the next chapter. The nephrotic syndrome — heavy proteinuria from podocyte/barrier injury — spans minimal change, FSGS, membranous, diabetic, and amyloid disease. The nephritic syndrome — haematuria, red-cell casts, and inflammation — spans IgA, post-infectious, lupus, MPGN, and the rapidly progressive vasculitides. The syndrome flows from the mechanism and the cell injured.

Repair, progression, and why podocytes matter

• Some injury is reversible (minimal change recovers completely); much is not. The pivotal fact is that podocytes are terminally differentiated and regenerate poorly — so once they are lost, the bared GBM scars and the glomerulus scleroses. This is why podocyte-depleting diseases progress to glomerulosclerosis, and why all glomerular disease, left unchecked, converges on the same final common pathway of interstitial fibrosis and tubular atrophy.

Five fully-built tables.

Table A — The filtration barrier

Table B — The glomerular cells

Table C — Immune mechanisms

Table D — Non-immune mechanisms

Table E — Immunofluorescence patterns

Visualise & Map

Causal chains, each ending in a named action.

Chain 1 — The leaking barrier

Podocyte injury → foot-process effacement and slit-diaphragm loss → protein floods the urine → nephrotic pattern → ACTION: think podocytopathy (minimal change, FSGS, membranous).

Chain 2 — The inflamed tuft

Endothelial/mesangial inflammation → capillary-wall breaks and proliferation → haematuria with red-cell casts → nephritic pattern → ACTION: think proliferative glomerulonephritis.

Chain 3 — The crescent

Severe injury (anti-GBM, ANCA, severe immune-complex) ruptures the capillary → parietal cells proliferate into Bowman's space → crescents → ACTION: recognise rapidly progressive GN as an emergency.

Chain 4 — Hyperfiltration

Diabetes / reduced nephron mass / obesity → raised intraglomerular pressure (hyperfiltration) → podocyte stress and secondary FSGS → ACTION: lower intraglomerular pressure (RAAS blockade).

Chain 5 — The irreplaceable podocyte

Podocytes are terminally differentiated → they regenerate poorly → their loss bares the GBM and scleroses the glomerulus → ACTION: protect podocytes early, before sclerosis is fixed.

Numbered rules. These numbers are the cross-reference handle for the cases and flowcharts.

Clinical Reasoning

Five cases. Each stops you at a decision before it answers it.

Every mechanism from Level 3 earns a bedside consequence and an action.

Exhaustive. Every rule in the chapter is here.

Safety & Evidence

Panel A — Red flags

Panel B — NEVER DO

Anti-patterns clinicians fall into. Each becomes a Level 22 distractor.

The grade reflects strength of evidence, not importance.

Apply & Test

Pre-rounds compression. Rules only.

Active recall. At least one card per objective.

Micro-teaching for rounds. Two scenarios, five steps each.

Nine items, each anchored in this chapter. At least one per objective.